ALL ABOUT MS Treatment (Part 11)

Treatment of relapse and some symptoms

Routine therapy for acute relapses is an intravenous high dose of corticosteroids, usually methylprednisolone at a dose of 500 to 1000 mg daily for three to five days. The aim of this therapy is to stop the attack as soon as possible in order to keep as little a consequence of this attack. Although generally effective in short-term symptom relief, corticosteroids do not have a significant impact on long-term recovery. In addition, longer therapy with corticosteroids can lead to osteoporosis, high blood pressure, psychotic reactions, convulsions, and cataracts.

Spasticity, which can be manifested as a permanent contraction caused by an increased muscle tone or transient spasm, is usually treated with muscle relaxants and mitralants such as baclofen, tizanidine, diazepam, clonazepam, and dantrolene. Physical therapy and exercises help preserve existing functions, while various aids, such as a walkway, a stick and a prosthesis, serve to keep the patient independent and mobile.

Treatment is strictly individual and requires close cooperation between patients, doctors, nurses, physiotherapists and family members. It consists of physical exercises, physical therapy, use of various mechanical aids, taking medications, and in the most severe cases, blocking of the nerves is also considered.

Avoiding excessive activity and heat are probably the most important measures a patient can take in the fight against bumps. If there are obvious and psychological symptoms of fatigue such as depression or apathy, they can help drugs from the group of antidepressants. Other drugs that can help with fatigue in a number of patients are amantadine (Symmetrel), pemolin (Cylert), and still an experimental drug aminopyridine.

In the case of balancing disorders, most commonly referred to as dizziness and floating, physical therapy and medicines such as dimenhydrinate (Dramamine), diphenhydramine (Dimidryl) and thietylperazine (Torecan) are generally used.

Tremor(tremor) is very difficult to treat and poorly responds to corticosteroid therapy. In the treatment, physical therapy, orthopedic aids are used, and in cases of severe chronic tremor where other measures do not help, surgery. Drugs used in the treatment of tremors are clonazepam (Rivotril), propranolol (Inderal, Propranolol), amantadine (Symmetrel, Amantadine), baclofen (Lioresal) and others, and their taking must be under the control of doctors.

Pain is a symptom that affects some 20-50% of MS patients in some form. Before treatment, it is very important to determine whether the pain is a symptom of MS or has some other cause. Some patients achieve pain relief by alternative therapies such as acupressure, acupuncture and therapeutic massage. Very rarely, pain in patients is so strong that they require specific treatment. In these cases, in addition to drugs from the group of analgesics, drugs from the group of tricyclic antidepressants and anticonvulsants are also given.

Comments

ALL ABOUT MS Treatment (Part 9)

ALL ABOUT MS Treatment (Part 9) Glatiramer acetate (Copaxone) This drug has similar effects and indications as interferon beta but a slightly different mechanism of action. It is applied at a dose of 20 mg, daily, subcutaneously. Side effects are also somewhat different, and include skin changes at the drug site and transient and short-term feeling of tightness in the chest with heart palpitations and a sense of lack of air. Natalizumab (Tysabri) This medicine is administered intravenously once a month. It works by preventing the immune system's entry into the brain and thus reducing the inflammatory (inflammatory) effect of immune cells on the nerve cells. Clinical trials have shown that natalizumab significantly reduces the incidence of attacks in the relapse form of MS, but in three patients it has caused a rare, but often fatal, brain disease. After this, the drug was withdrawn from the market, but in 2006 it was returned because of its positive effects o...

ALL ABOUT MS Treatment (Part 8)

Treatment Since research has shown that MS is an autoimmune disease, two basic approaches, immunosuppression (weakening of the immune response of the organism) and immunomodulation (changing the immune response) are used in the treatment. Numerous studies have shown that in the treatment of MS, the following drugs have success: interferon beta (betaferon, rebif, avonex), glatiramer acetate (copaxone), natalizumab (tysabri), mitoxantrone (novantrone) and some other cytostatics. Interferon beta Interferon beta is a protein that is a natural component of the human organism and is created by the cells of our immune system during defense reactions to external agents, primarily viruses. However, the most important effect this protein has is the so-called. Immunomodulatory effect: interferon beta promotes processes that mitigate the effects and slow down the ankle of multiple sclerosis, while the opposite inhibits it. The exact mechanism by which the interferon beta acts the...

ALL ABOUT MS Symptoms of MS (Part 4)

Urinary disorders About one-third of patients have sphincter disorders: an overwhelming need for urinary incontinence, which can sometimes be accompanied by frequent urination (so-called polacizuria), difficulty in urinating, retention (complete inability to urinate) and incontinence (loss of control over the process urinating, so that the urinary bladder empties reluctantly and unexpectedly). Urinary disorders can be accompanied by constipation and incontinence of the stool and impotence. Urinary disorders are very disturbing disorders, which significantly affect the quality of life, personal, professional and social functioning of the patients. Urinary disorders in MS are very common and occur in approximately 96% of patients with MS after 10 years of illness. Urinary disorders can occur at any time during the course of the disease, even at its inception (in about 2% of patients). Some researchers believe that patients in whom the disease begins with problems in the...

HUK

Search This Blog